Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4(+), CD8(+) T cells, and M1 macrophages

BACKGROUND: In 2016 the first-in-human phase I study of a miRNA-based cancer therapy with a liposomal mimic of microRNA-34a-5p (miR-34a-5p) was closed due to five immune related serious adverse events (SAEs) resulting in four patient deaths. For future applications of miRNA mimics in cancer therapy...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Immunother Cancer
Prif Awduron: Hart, Martin, Nickl, Laura, Walch-Rueckheim, Barbara, Krammes, Lena, Rheinheimer, Stefanie, Diener, Caroline, Taenzer, Tanja, Kehl, Tim, Sester, Martina, Lenhof, Hans-Peter, Keller, Andreas, Meese, Eckart
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2020
Pynciau:
Basic Tumor Immunology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7684812/
https://ncbi.nlm.nih.gov/pubmed/33229509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001617
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg